Mark Ogden
Overview
Mark Ogden received an average of $379K in total compensation at Enzon Pharmaceuticals from 2008 to 2010.
Source: SEC filing on April 8, 2011.
Related executives
We found 12 more executives who work or worked at Enzon Pharmaceuticals.
Richard Feinstein
Enzon Pharmaceuticals
Chief Financial Officer
Andrew Rackear
Enzon Pharmaceuticals
Chief Executive Officer
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
Timothy Daly
Enzon Pharmaceuticals
Chief Accounting Officer
Ana Stancic
Enzon Pharmaceuticals
Chief Financial Officer
Jeffrey Buchalter
Enzon Pharmaceuticals